Irregular delay of adjuvant chemotherapy correlated with poor outcome in stage II-III colorectal cancer

Irregular delay of adjuvant chemotherapy correlated with poor outcome in stage II-III colorectal cancer

Aims: Adjuvant chemotherapy (ACT) plays an important role in improving the survival of stage II-III colorectal cancer (CRC) patients after curative surgery. However, the prognostic role of irregular delay of ACT (IDacT) for these patients has been less studied. Materials and methods: A total of 117...

Full description

Bibliographic Details
Main Authors:	Chen, Y. (Author), Liu, L. (Author), Xiang, J. (Author), Xu, M. (Author), Xue, T. (Author), Yan, B. (Author), Yang, T. (Author), Ye, Q. (Author)
Format:	Article
Language:	English
Published:	BioMed Central Ltd 2022
Subjects:	Adjuvant chemotherapy Colorectal cancer Delay Disease-free survival
Online Access:	View Fulltext in Publisher

Similar Items

Effectiveness of adjuvant chemotherapy in patients with Stage II colorectal cancer: A multicenter retrospective study
by: Hasan Jalaeikhoo, et al.
Published: (2019-01-01)

The effect of adjuvant chemotherapy in stage 2 colorectal cancer
by: hormoz Mahmoudvand, et al.
Published: (2014-06-01)

Adjuvant Chemotherapy in Elderly Colorectal Cancer Patients
by: Bengt Glimelius, et al.
Published: (2020-08-01)

FIVE-YEAR CANCER-SPECIFIC SURVIVAL OF STAGE III COLORECTAL CANCER PATIENTS
by: V. Т. Kokhnyuk
Published: (2015-02-01)

Pathologic Factors Associated with Prognosis after Adjuvant Chemotherapy in Stage II/III Microsatellite-Unstable Colorectal Cancers
by: Jung Ho Kim, et al.
Published: (2015-03-01)

Cardiotoxic Profile and Arterial Stiffness of Adjuvant Chemotherapy for Colorectal Cancer
by: Visvikis A, et al.
Published: (2020-02-01)

Predictive models of adjuvant chemotherapy for patients with stage ii colorectal cancer: A retrospective study
by: Bo Wei, et al.
Published: (2017-01-01)

Adjuvant Chemotherapy for Stage III Colon Cancer
by: Julien Taieb, et al.
Published: (2020-09-01)

A network-based predictive gene-expression signature for adjuvant chemotherapy benefit in stage II colorectal cancer
by: Bangrong Cao, et al.
Published: (2017-12-01)

Precision medicine for adjuvant chemotherapy of resected colorectal cancer
by: Yuji Miyamoto, et al.
Published: (2020-11-01)

Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases – the multicenter randomized controlled PUMP trial
by: F. E. Buisman, et al.
Published: (2019-04-01)

Prognostic factors of adjuvant chemotherapy discontinuation among stage III colon cancer patients: A survey of medical oncologists and a systematic review and meta‐analysis
by: Devon J. Boyne, et al.
Published: (2020-03-01)

Chemotherapy and target therapy as neo-adjuvant approach for initially unresectable colorectal liver metastases
by: Luigi Rossi, et al.
Published: (2012-06-01)

An increase in the neutrophil-to-lymphocyte ratio during adjuvant chemotherapy indicates a poor prognosis in patients with stage II or III gastric cancer
by: Mikito Mori, et al.
Published: (2018-12-01)

Survival and time interval from surgery to the start of chemotherapy for patients with stage II and III colon cancer
by: Denis Ganenko, et al.
Published: (2019-01-01)

Impact of adjuvant chemotherapy on outcomes in appendiceal cancer
by: Bhaskar C. Kolla, et al.
Published: (2020-05-01)

Microsatellite instability and survival after adjuvant chemotherapy among stage II and III colon cancer patients: results from a population‐based study
by: Elizabeth Alwers, et al.
Published: (2020-02-01)

Evolution of Adjuvant Chemotherapy and Efficacy of Commonly Used Regimens in Colorectal Cancer
by: S.M. Adiga, et al.
Published: (2012-04-01)

Effect of Adjuvant Chemotherapy on DFS for Patients with Stage I NSCLC
by: Shengzu PENG, et al.
Published: (2017-06-01)

Predictive impact of the inflammation‐based indices in colorectal cancer patients with adjuvant chemotherapy
by: Yong Tao, et al.
Published: (2018-07-01)

The Impact of Neo-adjuvant and Adjuvant Chemotherapy in Treatment Outcome of Patients with High Risk Soft Tissue Sarcomas of the Extremities
by: Rasha Hamdy Hamed, et al.
Published: (2012-04-01)

3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT
by: Timothy Iveson, et al.
Published: (2019-12-01)

Is there a survival benefit from adjuvant chemotherapy for patients with liver oligometastases from colorectal cancer after curative resection?
by: Zhizhong Pan, et al.
Published: (2018-05-01)

Adjuvant Chemotherapy for Stage II Colon Cancer
by: Sara Elena Rebuzzi, et al.
Published: (2020-09-01)

Is adjuvant chemotherapy necessary for patients with microinvasive breast cancer after surgery?
by: Hai-Fei Niu, et al.
Published: (2016-03-01)

Essential Updates 2018/2019: Essential advances in surgical and adjuvant therapies for colorectal cancer
by: Tomonori Akagi, et al.
Published: (2020-01-01)

Perioperative Chemotherapy for Liver Metastasis of Colorectal Cancer
by: Gloria Chan, et al.
Published: (2020-11-01)

Predicting the effect of 5‐fluorouracil–based adjuvant chemotherapy on colorectal cancer recurrence: A model using gene expression profiles
by: Quan Chen, et al.
Published: (2020-05-01)

Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort study
by: Jakob Michael Riedl, et al.
Published: (2017-06-01)

The platelet to lymphocyte ratio is a potential inflammatory marker predicting the effects of adjuvant chemotherapy in patients with stage II colorectal cancer
by: Yu Fu, et al.
Published: (2021-07-01)

Survival analysis of elderly patients over 65 years old with stage II/III gastric cancer treated with adjuvant chemotherapy after laparoscopic D2 gastrectomy: a retrospective cohort study
by: Yanrui Liang, et al.
Published: (2021-02-01)

Prognostic value of lymphovascular invasion in stage II colorectal cancer patients with an inadequate examination of lymph nodes
by: Zhenyan Gao, et al.
Published: (2021-04-01)

Glutathione S-transferase Pi expression predicts response to adjuvant chemotherapy for stage C colon cancer: a matched historical control study
by: Jankova Lucy, et al.
Published: (2012-05-01)

Impact of adjuvant chemotherapy on the survival of patients with breast cancer diagnosed by screening
by: Irene Zarcos‐Pedrinaci, et al.
Published: (2019-11-01)

The Predictive Value of Estrogen Receptor 1 on Adjuvant Chemotherapy in Locally Advanced Colorectal Cancer: A Retrospective Analysis With Independent Validation and Its Potential Mechanism
by: Shu-Biao Ye, et al.
Published: (2020-03-01)

Histological phenotypic subtypes predict recurrence risk and response to adjuvant chemotherapy in patients with stage III colorectal cancer
by: Antonia K Roseweir, et al.
Published: (2020-10-01)

Real-World Effectiveness of Adjuvant Oxaliplatin Chemotherapy in Stage III Colon Cancer: A Controlled Interrupted Time Series Analysis
by: Wen-Kuan Huang, et al.
Published: (2021-06-01)

Adjuvant chemotherapy is an additional option for locally advanced gastric cancer after radical gastrectomy with D2 lymphadenectomy: a retrospective control study
by: Lei Chen, et al.
Published: (2021-08-01)

Benefit of adjuvant chemoradiotherapy in patients with pathological stage III gastric cancer
by: Ma GF, et al.
Published: (2019-07-01)

Timing of Adjuvant Chemotherapy and Survival in Colorectal, Gastric, and Pancreatic Cancer. A Systematic Review and Meta-Analysis
by: Fausto Petrelli, et al.
Published: (2019-04-01)